Early thyroxine treatment in Down syndrome and thyroid function later in life
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Objective: The hypothalamus–pituitary–thyroid (HPT) axis set point develops during the fetal period and first two years of life. We hypothesized that thyroxine treatment during these first two years, in the context of a randomized controlled trial (RCT) in children with Down syndrome, may have influenced the HPT axis set point and may also have influenced the development of Down syndrome-associated autoimmune thyroiditis. Methods: We included 123 children with Down syndrome 8.7 years after the end of an RCT comparing thyroxine treatment vs placebo and performed thyroid function tests and thyroid ultrasound. We analyzed TSH and FT4 concentrations in the subgroup of 71 children who were currently not on thyroid medication and had no evidence of autoimmune thyroiditis. Results: TSH concentrations did not differ, but FT4 was significantly higher in the thyroxine-treated group than that in the placebo group (14.1 vs 13.0 pmol/L; P = 0.02). There was an increase in anti-TPO positivity, from 1% at age 12 months to 6% at age 24 months and 25% at age 10.7 years with a greater percentage of children with anti-TPO positivity in the placebo group (32%) compared with the thyroxine-treated group (18.5%) (P = 0.12). Thyroid volume at age 10.7 years (mean: 3.4 mL; range: 0.5–7.5 mL) was significantly lower (P < 0.01) compared with reference values (5.5 mL; range: 3–9 mL) and was similar in the thyroxine and placebo group. Conclusion: Thyroxine treatment during the first two years of life led to a mild increase in FT4 almost 9 years later on and may point to an interesting new mechanism influencing the maturing HPT axis set point. Furthermore, there was a trend toward less development of thyroid autoimmunity in the thyroxine treatment group, suggesting a protective effect of the early thyroxine treatment. Lastly, thyroid volume was low possibly reflecting Down-specific thyroid hypoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson, B., Gustafsson, J., Hedov, G., Ivarsson, S.-A., & Anneren, G. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.3.242 · Cited by 279
Hadlow, N. C., Rothacker, K. M., Wardrop, R., Brown, S. J., Lim, E. M., & Walsh, J. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4223 · Cited by 203
Fasting-Induced Changes in the Hypothalamus–Pituitary–Thyroid Axis
Boelen, A., Wiersinga, W. M., & Fliers, E. (2008) · Thyroid · doi:10.1089/thy.2007.0253 · Cited by 194
Self-citationKempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., & Vulsma, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030665 · Cited by 160
van Trotsenburg, A. S. P., Vulsma, T., van Rozenburg-Marres, S. L. R., van Baar, A. L., Ridder, J. C. D., Heymans, H. S. A., Tijssen, J. G. P., & de Vijlder, J. J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0130 · Cited by 130
Maturation of Human Hypothalamic-Pituitary-Thyroid Function and Control
Fisher, D. A., Nelson, J. C., Carlton, E. I., & Wilcox, R. B. (2000) · Thyroid · doi:10.1089/thy.2000.10.229 · Cited by 128
Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort
Panicker, V., Wilson, S. G., Spector, T. D., Brown, S. J., Falchi, M., Richards, J. B., Surdulescu, G. L., Lim, E. M., Fletcher, S. J., & Walsh, J. P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03079.x · Cited by 128
MECHANISMS IN ENDOCRINOLOGY: Beyond the fixed setpoint of the hypothalamus–pituitary–thyroid axis
Fliers, E., Kalsbeek, A., & Boelen, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0285 · Cited by 124
Self-citationLower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns
van Trotsenburg, A. S. P., Vulsma, T., van Santen, H. M., Cheung, W., & de Vijlder, J. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021303 · Cited by 118
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Multiorgan involvement and management in children with Down syndrome
Lagan, N., Huggard, D., McGrane, F., Leahy, T. R., Franklin, O., Roche, E. F., Webb, D. W., Marcaigh, A. O., Cox, D., EL-Khuffash, A. F., et al. (2020) · Acta Paediatrica · doi:10.1111/apa.15153 · Cited by 127
Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence
Kyritsi, E. M., & Kanaka‐Gantenbein, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00543 · Cited by 125
Endocrine manifestations of Down syndrome
Whooten, R., Schmitt, J. A., & Schwartz, A. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000382 · Cited by 112
Hashimoto’s Thyroiditis and Graves’ Disease in Genetic Syndromes in Pediatric Age
Casto, C., Pepe, G., Pomi, A. L., Corica, D., Aversa, T., & Wasniewska, M. G. (2021) · Genes · doi:10.3390/genes12020222 · Cited by 72
Metadata
- Authors
- Zwaveling-Soonawala, N., Witteveen, M. E., Marchal, J. P., Klouwer, F. C. C., Ikelaar, N. A., Smets, A. M. J. B., van Rijn, R. R., Endert, E., Fliers, E., & van Trotsenburg, A. S. P.
- Affiliations
- Emma Kinderziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05
- Volume
- 176
- Issue
- 5
- Pages
- 505-513
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2582317675
- Cited by
- 23
- References
- 29
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 1
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- Down syndrome, thyroxine therapy, hypothalamic-pituitary-thyroid axis, autoimmune thyroiditis, thyroid peroxidase antibodies, thyroid function, free thyroxine, thyroid volume, thyroid hypoplasia
- MeSH terms
- Adult, Age Factors, Child, Down Syndrome, Female, Follow-Up Studies, Humans, Male, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early thyroxine treatment in Down syndrome and thyroid function later in life. https://app.cochat.ai/papers/10.1530/eje-16-0858
- The paper
- Zwaveling-Soonawala, N., Witteveen, M. E., Marchal, J. P., Klouwer, F. C. C., Ikelaar, N. A., Smets, A. M. J. B., van Rijn, R. R., Endert, E., Fliers, E., & van Trotsenburg, A. S. P. (2017). Early thyroxine treatment in Down syndrome and thyroid function later in life. European Journal of Endocrinology. https://doi.org/10.1530/eje-16-0858
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.